Unknown

Dataset Information

0

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.


ABSTRACT: Human immunodeficiency virus type 1 (HIV-1) DNA dynamics during long-term antiretroviral therapy (ART) are not defined.Blood mononuclear cells obtained during 7-12 years of effective ART were assayed for total HIV-1 DNA and 2-long terminal repeat (LTR) circles by quantitative polymerase chain reaction (qPCR). Slopes of HIV-1 DNA were estimated by participant-specific linear regressions. Plasma was assayed for residual viremia (HIV-1 RNA) by qPCR.Thirty participants were studied. HIV-1 DNA decreased significantly from years 0-1 and 1-4 of ART with median decay slopes of -0.86 (interquartile range, -1.05, -0.59) and -0.11 (-0.17, -0.06) log10(copies/10(6) CD4+ T-cells)/year, respectively (P < .001). Decay was not significant for years 4-7 (-0.02 [-0.06, 0.02]; P = .09) or after year 7 of ART (-0.006 [-0.030, 0.015]; P = .17). All participants had detectable HIV-1 DNA after 10 years (median 439 copies/10(6) CD4+ T-cells; range: 7-2074). Pre-ART HIV-1 DNA levels were positively associated with pre-ART HIV-1 RNA levels (Spearman = 0.71, P < .001) and with HIV-1 DNA at years 4, 7, and 10 on ART (Spearman ? 0.75, P < .001). No associations were found (P ? .25) between HIV-1 DNA slopes or levels and % activated CD8+ T-cells (average during years 1-4) or residual viremia (n = 18). 2-LTR circles were detected pre-ART in 20/29 and in 8/30 participants at last follow-up.Decay of HIV-1 DNA in blood is rapid in the first year after ART initiation (86% decline), slows during years 1-4 (23% decline/year), and subsequently plateaus. HIV-1 DNA decay is not associated with the levels of CD8+ T-cell activation or persistent viremia. The determinants of stable HIV-1 DNA persistence require further elucidation. Clinical Trials Registration.?NCT00001137.

SUBMITTER: Besson GJ 

PROVIDER: S-EPMC4200019 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

Besson Guillaume J GJ   Lalama Christina M CM   Bosch Ronald J RJ   Gandhi Rajesh T RT   Bedison Margaret A MA   Aga Evgenia E   Riddler Sharon A SA   McMahon Deborah K DK   Hong Feiyu F   Mellors John W JW  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20140729 9


<h4>Background</h4>Human immunodeficiency virus type 1 (HIV-1) DNA dynamics during long-term antiretroviral therapy (ART) are not defined.<h4>Methods</h4>Blood mononuclear cells obtained during 7-12 years of effective ART were assayed for total HIV-1 DNA and 2-long terminal repeat (LTR) circles by quantitative polymerase chain reaction (qPCR). Slopes of HIV-1 DNA were estimated by participant-specific linear regressions. Plasma was assayed for residual viremia (HIV-1 RNA) by qPCR.<h4>Results</h4  ...[more]

Similar Datasets

| S-EPMC7101154 | biostudies-literature
| S-EPMC7857155 | biostudies-literature
| S-EPMC9668181 | biostudies-literature
| S-EPMC6694813 | biostudies-literature
| S-EPMC6686847 | biostudies-literature
| S-EPMC4657623 | biostudies-literature
| S-EPMC3961343 | biostudies-literature
| S-EPMC6391194 | biostudies-literature
| S-EPMC6425167 | biostudies-literature
| S-EPMC7850524 | biostudies-literature